Definium Therapeutics, Inc. Diluted Shares Outstanding (Weighted Average)
Definium Therapeutics, Inc. (DFTX) reported Diluted Shares Outstanding (Weighted Average) of 110.68 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- Definium Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 110.68M shares, a 29.69% increase year-over-year.
- Definium Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 108.79M shares, a 24.92% increase year-over-year.
- Definium Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 101.00M shares, a 20.20% increase year-over-year.
- Definium Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 85.89M shares, a 7.04% increase year-over-year.
- Definium Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 89.33M shares, a 26.78% increase from fiscal 2024.
- Definium Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 70.46M shares, a 79.94% increase from fiscal 2023.
- Definium Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 39.16M shares, a 26.90% increase from fiscal 2022.
- Definium Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 30.86M shares, a 12.71% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 110.68M shares 10-Q · filed 2026-08-06 | 109.74M shares 10-Q · filed 2026-08-06 | 106.83M shares derived: average of 3 quarters · filed 2026-08-06 | 101.59M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | 108.79M shares 10-Q · filed 2026-05-07 | 104.90M shares derived: average of 2 quarters · filed 2026-05-07 | 98.56M shares derived: average of 3 quarters · filed 2026-05-07 | 95.26M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | 101.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 93.44M shares derived: average of 2 quarters · filed 2026-02-26 | 90.74M shares derived: average of 3 quarters · filed 2026-08-06 | 89.33M shares 10-K · filed 2026-02-26 | ||
| 2025-09-30 | 85.89M shares 10-Q · filed 2025-11-06 | 85.62M shares derived: average of 2 quarters · filed 2026-08-06 | 85.44M shares 10-Q · filed 2025-11-06 | 85.59M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | 85.35M shares 10-Q · filed 2026-08-06 | 87.10M shares 10-Q · filed 2026-08-06 | 85.49M shares derived: average of 3 quarters · filed 2026-08-06 | 84.18M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | 87.09M shares 10-Q · filed 2026-05-07 | 85.56M shares derived: average of 2 quarters · filed 2026-05-07 | 83.79M shares derived: average of 3 quarters · filed 2026-05-07 | 81.67M shares derived: average of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | 84.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 82.13M shares derived: average of 2 quarters · filed 2026-02-26 | 79.86M shares derived: average of 3 quarters · filed 2026-02-26 | 70.46M shares 10-K · filed 2026-02-26 | ||
| 2024-09-30 | 80.24M shares 10-Q · filed 2025-11-06 | 77.77M shares derived: average of 2 quarters · filed 2025-11-06 | 65.94M shares 10-Q · filed 2025-11-06 | 60.91M shares derived: average of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | 75.30M shares 10-Q · filed 2025-07-31 | 59.89M shares 10-Q · filed 2025-07-31 | 54.47M shares derived: average of 3 quarters · filed 2025-07-31 | 50.78M shares derived: average of 4 quarters · filed 2025-07-31 | ||
| 2024-03-31 | 47.86M shares 10-Q · filed 2025-05-08 | 44.05M shares derived: average of 2 quarters · filed 2025-05-08 | 42.61M shares derived: average of 3 quarters · filed 2025-05-08 | 41.60M shares derived: average of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | 40.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 39.98M shares derived: average of 2 quarters · filed 2025-03-06 | 39.51M shares derived: average of 3 quarters · filed 2025-03-06 | 39.16M shares 10-K · filed 2025-03-06 | ||
| 2023-09-30 | 39.72M shares 10-Q · filed 2024-11-07 | 39.15M shares derived: average of 2 quarters · filed 2024-11-07 | 38.80M shares 10-Q · filed 2024-11-07 | 38.53M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 38.58M shares 10-Q · filed 2024-08-13 | 38.33M shares 10-Q · filed 2024-08-13 | 38.13M shares derived: average of 3 quarters · filed 2024-08-13 | 35.92M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 38.08M shares 10-Q · filed 2024-05-08 | 37.90M shares derived: average of 2 quarters · filed 2024-05-08 | 35.03M shares derived: average of 3 quarters · filed 2024-05-08 | 33.34M shares derived: average of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | 37.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 33.51M shares derived: average of 2 quarters · filed 2024-02-28 | 31.76M shares derived: average of 3 quarters · filed 2024-02-28 | 30.86M shares 10-K · filed 2024-02-28 | ||
| 2022-09-30 | 29.30M shares 10-Q · filed 2023-11-02 | 28.77M shares derived: average of 2 quarters · filed 2023-11-02 | 28.57M shares 10-Q · filed 2023-11-02 | 28.46M shares derived: average of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | 28.24M shares 10-Q · filed 2023-08-03 | 423.63M shares 10-Q · filed 2022-08-11 | 28.20M shares 10-Q · filed 2023-08-03 | 422.95M shares 10-Q · filed 2022-08-11 | 28.17M shares derived: average of 3 quarters · filed 2023-08-03 | 28.13M shares derived: average of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | 28.15M shares 10-Q · filed 2023-05-04 | 28.14M shares derived: average of 2 quarters · filed 2023-05-04 | 28.10M shares derived: average of 3 quarters · filed 2023-05-04 | 123.78M shares derived: average of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | 28.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 28.07M shares derived: average of 2 quarters · filed 2023-03-09 | 155.66M shares derived: average of 3 quarters · filed 2023-03-09 | 27.38M shares 10-K · filed 2023-03-09 | ||
| 2021-09-30 | 28.01M shares 10-Q · filed 2022-11-10 | 219.42M shares derived: average of 2 quarters · filed 2022-11-10 | 27.12M shares 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | 410.82M shares 10-Q · filed 2022-08-11 | 400.32M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |